Date
Attendees
Committee Member | Present | Absent |
---|---|---|
X | ||
X | ||
X | ||
X | ||
Gregory Tawa | X | |
William Hendriks | X | |
Matthew Breen | X | |
Roel Verhaak | X |
Goals
- Review, discuss, and prioritize ICDC study submission proposals
Outstanding Action items
- Matthew & Warren to write an email request to Toby pertaining to formalization of a business plan for ICDC.
- Musk, Philip (NIH/NCI) [C] to brush up on Nanostring documentation.
- Kuffel, Gina (NIH/NCI) [C] to organize and circulate other Modiano publications that have genomic data available
Agenda
Discussion Item | Who | Notes |
---|---|---|
PRECINCT Data Request Submission: Inhaled IL-15 Immunotherapy for Treatment of Lung Metastases | All |
|
Review of other Modiano publications: Other Modiano Publication Considerations.xlsx |
| |
Study Updates |
|
Minutes (Not Verbatim)
Warren - Take this submission request to a vote.
WK - This is the first NanoString data submission. That is an advantage of this program as well.
PM - Correct. Even if this study is thin on data as of release, we are set up for handling similar datasets coming out of the other PRECINCT trials. This will involve new data types and data model changes.
Voting for PRECINCT submission: Warren, Will, and Greg recommend to bring in the study.
PM - Are there are study level files for the OSA01 study?
WH - Heather can provide those.